Anti-radiation damage effect of polyethylenimine as a toll-like receptor 5 targeted agonist
Autor: | Zhongbin Chen, Kai Wang, Jian Tu, Lening Ren, Xiaojuan Chen, Yuanyu Qian, Yaling Xing, Zhiqiang Hu |
---|---|
Rok vydání: | 2012 |
Předmět: |
Agonist
Cell Survival medicine.drug_class Health Toxicology and Mutagenesis Radiation-Protective Agents total body irradiation (TBI) Pharmacology Radiation Dosage Radiation Tolerance NF-κB Mice chemistry.chemical_compound medicine Animals Humans Polyethyleneimine Radiology Nuclear Medicine and imaging Receptor Biology Toll-like receptor 5 (TLR5) Polyethylenimine Radiation Dose-Response Relationship Drug Chemistry NF-kappa B Dose-Response Relationship Radiation Amifostine Total body irradiation Mice Inbred C57BL Survival Rate Toll-Like Receptor 5 Dose–response relationship HEK293 Cells Treatment Outcome Acute Radiation Syndrome TLR5 Immunology Polyethylenimine (PEI) radiation protection Whole-Body Irradiation medicine.drug |
Zdroj: | Journal of Radiation Research |
ISSN: | 1349-9157 0449-3060 |
Popis: | A number of agents are now available for use in protecting against ionizing radiation. These radiation-protective agents, however, have many adverse effects. Efforts have been made to develop new radiation-protective agents for medical application. Here, we investigated whether a compound, polyethylenimine (PEI), which activates Toll-like receptor 5 (TLR5)-mediated NF-kB signaling pathways, could have an anti-radiation effect on a mouse model. First, a cell-based screening model for an agonist of TLR5-mediated NF-kB pathway was established and then validated by activation of TLR5-mediated NF-kB luciferase reporter activity with a known TLR5 agonist, flagellin. We found that PEI induced dose-dependent activation of the TLR5-mediated NF-kB pathway, indicating that PEI is indeed a TLR5 agonist. Furthermore, the anti-radiation effect of polyethylenimine was assessed using a γ-ray total body irradiation (TBI) mouse model. Compared with the irradiation control, both survival time and survival rate were significantly improved in mice that received either a low dose of polyethylenimine (P= 0.019) or a high dose of polyethylenimine (P< 0.001). We also observed a positive correlation between animal body weight and survival time in mice that received a low dose of polyethylenimine, a high dose of polyethylenimine and amifostine, over a period of 30 days, r= 0.42 (P< 0.02), 0.72 (P< 0.0001) and 0.95 (P< 0.0001), respectively, while a negative correlation between animal body weight and survival time was observed in the irradiation control (r= –0.89; P< 0.0001). These results indicate that polyethylenimine is a new TLR5 agonist with potential application in offering protection for patients receiving radiotherapy or in radiation-related accidents. |
Databáze: | OpenAIRE |
Externí odkaz: |